Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
Study First Submitted
Endpoints
Primary
Proportion of Participants With a Modified Rankin Scale (mRS) Score of 0-1
Timeframe: 90 ± 7 days after randomization
Secondary (16)
Proportion of Participants With a Modified Rankin Scale (mRS) Score of 0-2
Distribution of Modified Rankin Scale (mRS) Scores
Proportion of Participants With a National Institutes of Health Stroke Scale (NIHSS) Score of 0-1
Proportion of Participants With an Increase From Baseline of ≥2 Points in Total NIHSS Score or ≥1 Point in Any Motor Item Score
Proportion of Participants With a Decrease From Baseline of ≥2 Points in Total NIHSS Score or ≥1 Point in Any Motor Item Score
Show 11 moreShow less
Proportion of Participants With a COSMOS score Grade of 0-1
COSMOS Score
Health-Related Quality of Life Assessed by EQ-5D-3L and EQ VAS
Incidence of Symptomatic Intracranial Hemorrhage According to ECASS III Criteria Within 36 Hours
Incidence of Any Intracranial Hemorrhage Within 36 Hours
Incidence of Symptomatic Intracranial Hemorrhage According to ECASS III Criteria Within 7 Days
Incidence of Major Extracranial Bleeding According to ISTH Criteria
Proportion of Participants With a Modified Rankin Scale (mRS) Score of 5-6
All-Cause Mortality
Proportion of Participants Experiencing at Least One Adverse Event
Proportion of Participants Experiencing at Least One Serious Adverse Event
Arms and interventions
Low-Dose Tenecteplase (rhTNK-tPA)Experimental
Participants will receive rhTNK-tPA at 0.18 mg/kg, with a maximum dose of 16 mg, administered as a single intravenous bolus over 5 to 10 seconds within 4.5 hours after stroke onset. Participants will also receive standard stroke care according to current clinical guidelines.
Participants will receive rhTNK-tPA at 0.25 mg/kg, with a maximum dose of 25 mg, administered as a single intravenous bolus over 5 to 10 seconds within 4.5 hours after stroke onset. Participants will also receive standard stroke care according to current clinical guidelines.